BR9809994A - Composição farmacêutica para uso no tratamento da sìndrome do intestino irritável, diarréia, constipação, dor abdominal e/ou inchamento ou distensão abdominal em um mamìfero, uso de um ou mais compostos de vanilóide, seus sais, análogos e derivados famaceuticamente aceitáveis, e, processos para tratamento da sìndrome do intestino irritável, diarréia, constipação, dor abdominal e/ou inchamento ou distensão abdominal de um mamìfero e para a fabricação de uma composição - Google Patents

Composição farmacêutica para uso no tratamento da sìndrome do intestino irritável, diarréia, constipação, dor abdominal e/ou inchamento ou distensão abdominal em um mamìfero, uso de um ou mais compostos de vanilóide, seus sais, análogos e derivados famaceuticamente aceitáveis, e, processos para tratamento da sìndrome do intestino irritável, diarréia, constipação, dor abdominal e/ou inchamento ou distensão abdominal de um mamìfero e para a fabricação de uma composição

Info

Publication number
BR9809994A
BR9809994A BR9809994-9A BR9809994A BR9809994A BR 9809994 A BR9809994 A BR 9809994A BR 9809994 A BR9809994 A BR 9809994A BR 9809994 A BR9809994 A BR 9809994A
Authority
BR
Brazil
Prior art keywords
abdominal
treatment
constipation
diarrhea
bowel syndrome
Prior art date
Application number
BR9809994-9A
Other languages
English (en)
Inventor
Fiona Kate Gardiner
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of BR9809994A publication Critical patent/BR9809994A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA PARA USO NO TRATAMENTO DA SìNDROME DO INTESTINO IRRITáVEL, DIARRéIA, CONSTIPAçãO, DOR ABDOMINAL E/OU INCHAMENTO OU DISTENSãO ABDOMINAL EM UM MAMìFERO, USO DE UM OU MAIS COMPOSTOS DE VANILóIDE, SEUS SAIS ANáLOGOS E DERIVADOS FARMACEUTICAMENTE ACEITáVEIS, E, PROCESSOS PARA TRATAMENTO DA SìNDROME DO INTESTINO IRRITáVEL, DIARRéIA, CONSTIPAçãO, DOR ABDOMINAL E/OU INCHAMENTO OU DISTENSãO ABDOMINAL DE UM MAMìFERO E PARA A FABRICAçãO DE UMA COMPOSIçãO". é fornecida uma composição farmacêutica para tratamento da síndrome do intestino irritável, composição esta incluindo um veículo portador e um composto vanilóide. O veículo portador possibilita que o composto vanilóide seja liberado no trato GI inferior. O composto vanilóide tem o efeito de dessensibilizar os nervos do trato GI inferior, conduzido ao alívio de sintomas da síndrome do intestino irritável.
BR9809994-9A 1997-06-10 1998-06-08 Composição farmacêutica para uso no tratamento da sìndrome do intestino irritável, diarréia, constipação, dor abdominal e/ou inchamento ou distensão abdominal em um mamìfero, uso de um ou mais compostos de vanilóide, seus sais, análogos e derivados famaceuticamente aceitáveis, e, processos para tratamento da sìndrome do intestino irritável, diarréia, constipação, dor abdominal e/ou inchamento ou distensão abdominal de um mamìfero e para a fabricação de uma composição BR9809994A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711962.2A GB9711962D0 (en) 1997-06-10 1997-06-10 Therapeutically active compositions
PCT/GB1998/001673 WO1998056356A1 (en) 1997-06-10 1998-06-08 Therapeutically active compositions

Publications (1)

Publication Number Publication Date
BR9809994A true BR9809994A (pt) 2000-08-01

Family

ID=10813845

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809994-9A BR9809994A (pt) 1997-06-10 1998-06-08 Composição farmacêutica para uso no tratamento da sìndrome do intestino irritável, diarréia, constipação, dor abdominal e/ou inchamento ou distensão abdominal em um mamìfero, uso de um ou mais compostos de vanilóide, seus sais, análogos e derivados famaceuticamente aceitáveis, e, processos para tratamento da sìndrome do intestino irritável, diarréia, constipação, dor abdominal e/ou inchamento ou distensão abdominal de um mamìfero e para a fabricação de uma composição

Country Status (17)

Country Link
US (1) US6201014B1 (pt)
EP (1) EP0988028B1 (pt)
JP (1) JP2002513418A (pt)
KR (1) KR20010013618A (pt)
CN (1) CN1198594C (pt)
AR (1) AR012960A1 (pt)
AT (1) ATE262892T1 (pt)
AU (1) AU737606B2 (pt)
BR (1) BR9809994A (pt)
CA (1) CA2291796C (pt)
DE (1) DE69822822T2 (pt)
GB (3) GB9711962D0 (pt)
HU (1) HUP0004245A2 (pt)
ID (1) ID22878A (pt)
PL (1) PL337337A1 (pt)
WO (1) WO1998056356A1 (pt)
ZA (1) ZA984920B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790207B2 (en) * 1998-06-04 2004-09-14 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract
US20110071468A1 (en) * 1998-06-04 2011-03-24 Mederi Therapeutics, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
US6802841B2 (en) * 1998-06-04 2004-10-12 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
GB9812426D0 (en) * 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB9925127D0 (en) * 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
WO2001064202A2 (en) * 2000-03-01 2001-09-07 Euro-Celtique S.A. Tramadol for the treatment of functional gastrointestinal disorders
US7192612B2 (en) * 2001-02-22 2007-03-20 Purdue Research Foundation Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
US6759064B2 (en) 2001-02-22 2004-07-06 Purdue Research Foundation Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
US6428822B1 (en) 2001-04-03 2002-08-06 Chengzhi Life Science Company, Ltd. Extracts of mixed arctium lappa L., carrot and whole radish for treating hypertension, constipation and detoxification
US6682759B2 (en) * 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
AU2003225372A1 (en) * 2002-04-12 2003-10-27 Pangenomics Co., Ltd Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases
US20050058734A1 (en) * 2002-12-18 2005-03-17 Algorx Administration of capsaicinoids
ES2562025T3 (es) * 2002-12-18 2016-03-02 Centrexion Therapeutics Corporation Administración de capsaicinoides para el tratamiento de la artrosis
WO2004092122A2 (en) * 2003-04-08 2004-10-28 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
US20100159000A1 (en) * 2003-11-10 2010-06-24 Lundeen Sr James E Medicine for treating gastrointestinal disorder including fecal incontinence
AT413646B (de) * 2004-04-02 2006-04-15 Hammer Johann Dr Verwendung von capsaicin und/oder capsaicinoiden
US20050277657A1 (en) * 2004-06-15 2005-12-15 Dusan Ninkov Method of protection of biologically active essential oils and pharmaceutical composition for weight control and enhance fat burning in adults, adolescents and children
US20060148903A1 (en) * 2004-11-24 2006-07-06 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
DK1838301T3 (en) 2004-12-28 2015-04-27 Mestex Ag Use of resiniferate toxin (RTX) for the preparation of a pain management agent
JP5550907B2 (ja) 2006-10-27 2014-07-16 ビー・エム・ビー・パテント・ホールデイング・コーポレイシヨン 治療組成物およびカプシアノシド型化合物による治療方法
WO2009029841A1 (en) * 2007-08-29 2009-03-05 Sorbent Therapeutics, Inc. Absorbent polymeric compositions with varying counterion content and their methods of preparation and use
KR20090047637A (ko) * 2007-11-08 2009-05-13 재단법인서울대학교산학협력재단 커큐민 또는 이의 약학적으로 허용가능한 염을유효성분으로 함유하는 통증 예방 및 치료용 조성물
HUP0700755A2 (en) * 2007-11-26 2009-08-28 Pannonpharma Gyogyszergyar Pharmaceutical compositions containing capsaicionoid and non-steroidal anti-inflammatory drug
US8697155B2 (en) * 2008-07-22 2014-04-15 Mayo Foundation For Medical Education And Research Treatment of obesity and related disorders
US20110200669A1 (en) * 2010-02-15 2011-08-18 Winston Laboratories, Inc. Method and compositions of civamide to treat disease of the intestines
KR101378973B1 (ko) * 2012-04-13 2014-03-28 한미약품 주식회사 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법
CN103027901B (zh) * 2012-12-11 2014-11-12 广东药学院 一种载辣椒素壳聚糖微球肠溶片及其制备方法
US10092528B2 (en) 2013-03-13 2018-10-09 Altria Client Services Llc Application of encapsulated capsaicin and analogues thereof for controlling calorie intake
US9289418B2 (en) 2013-03-15 2016-03-22 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
AU2014239164B2 (en) 2013-03-15 2018-12-06 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
BR112016017244A2 (pt) * 2014-01-30 2017-08-08 Omniactive Health Tech Limited Composições de substâncias oleosas, pungentes e odoríferas e processo de preparação das mesmas
RU2697851C2 (ru) 2014-08-13 2019-08-21 Седарс-Синаи Медикал Сентер Антиметаногенные композиции и их применение
EP3277274B1 (en) 2015-04-01 2024-06-12 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
AU2019457560A1 (en) * 2019-07-18 2022-02-17 Dignify Therapeutics, Llc Compositions and methods for inducing defecation
WO2021209450A1 (en) * 2020-04-15 2021-10-21 Mestex Ag Resiniferatoxin compositions
JP2024505139A (ja) * 2021-01-15 2024-02-05 ディグニファイ セラピューティクス エルエルシー 排便を誘発するための組成物及び方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2207705A1 (en) * 1972-11-24 1974-06-21 Marconnet Rene Deodorisation of body odours - by liberation of odoriferous substances in the intestines
EP0015334B1 (en) 1977-08-04 1982-05-19 J.B. Tillott Limited Carminative preparations containing peppermint oil or its active components
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
HU206082B (en) * 1988-12-23 1992-08-28 Sandoz Ag Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds
US5403868A (en) 1988-12-23 1995-04-04 Sandoz Ltd. Capsaicin derivatives
US5063060A (en) * 1989-12-19 1991-11-05 Cisco Limited Partnership Compositions and method for treating painful, inflammatory or allergic disorders
DE4137540A1 (de) * 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
US5431914A (en) 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption
WO1993023061A1 (en) * 1992-05-21 1993-11-25 Staggs Jeff J Therapeutic uses of pungent botanicals and their related compounds
US5762963A (en) 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
EP0839037B1 (en) 1995-07-14 2002-11-13 Sabinsa Corporation Bioprotectant composition, method of use and extraction process of curcuminoids

Also Published As

Publication number Publication date
ID22878A (id) 1999-12-16
PL337337A1 (en) 2000-08-14
AU7782998A (en) 1998-12-30
US6201014B1 (en) 2001-03-13
JP2002513418A (ja) 2002-05-08
CA2291796C (en) 2008-03-25
CA2291796A1 (en) 1998-12-17
WO1998056356A1 (en) 1998-12-17
GB9827192D0 (en) 1999-02-03
GB2332147B (en) 1999-10-27
ZA984920B (en) 1999-07-01
DE69822822T2 (de) 2005-01-13
EP0988028B1 (en) 2004-03-31
GB2332147A (en) 1999-06-16
GB9811819D0 (en) 1998-07-29
CN1259863A (zh) 2000-07-12
GB9711962D0 (en) 1997-08-06
EP0988028A1 (en) 2000-03-29
ATE262892T1 (de) 2004-04-15
AU737606B2 (en) 2001-08-23
HUP0004245A2 (hu) 2001-08-28
AR012960A1 (es) 2000-11-22
KR20010013618A (ko) 2001-02-26
CN1198594C (zh) 2005-04-27
DE69822822D1 (de) 2004-05-06

Similar Documents

Publication Publication Date Title
BR9809994A (pt) Composição farmacêutica para uso no tratamento da sìndrome do intestino irritável, diarréia, constipação, dor abdominal e/ou inchamento ou distensão abdominal em um mamìfero, uso de um ou mais compostos de vanilóide, seus sais, análogos e derivados famaceuticamente aceitáveis, e, processos para tratamento da sìndrome do intestino irritável, diarréia, constipação, dor abdominal e/ou inchamento ou distensão abdominal de um mamìfero e para a fabricação de uma composição
BR9808422A (pt) Composto, composição farmacêutica, processos para induzir paralisia neuromuscular em um mamìfero e para a preparação de um composto, e, uso de um composto
BR0009835A (pt) Formulação farmacêutica, uso da mesma, métodos para tratamento profilático ou terapêutico de um indivìduo que sofre, ou susceptìvel à hipercolesterolemia, e a diarréia, e, uso de um aglutinante de ácido da bile
BR9809481A (pt) Composto, processo para sua preparação, uso do mesmo, composição farmacêutica, e, processos para sua preparação, para efetuar a imunossupressão e para tratar ou reduzir o risco de uma doença obstrutiva reversìvel das vias aéreas em um paciente
BR9713785A (pt) Composto, uso do mesmo, agente de diagnóstico, composição farmacêutica, e, processos para a preparação de um composto e para o tratamento da dor, de distúrbios gastrointestinais e de lesões na coluna vertebral.
DE69725293D1 (de) N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
FI900052A (fi) Kompositioner och behandlingsmetoder foer hemorrojder och annat.
BR9911073A (pt) Uso de uma composição compreendendo formoterol e budesonida para a prevenção ou tratamento de uma condição aguda de asma
BRPI0317463B8 (pt) composto, composição farmacêutica compreendendo o mesmo e uso do referido composto no preparo de um medicamento para tratar uma doença amilóide de transtiretina
BR0115847A (pt) Compostos especìficos para receptor para adenosina a1, a2a, e a3 e usos dos mesmos
KR960703009A (ko) 중추유래의 수면성 무호흡증 및 호흡곤란증의 치료를 위한 모다피닐의 사용
KR880002515A (ko) 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물
BR0317349A (pt) Droga sólida para uso oral
BR9713921A (pt) Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa
BR9608252A (pt) Combinação de um primeiro componente que é um inibidor de reabsorção de 5-ht e um segundo componente que é antagonista de 5-th uso da combinação processos para o tratamento de disúrbios efetivos e da depressão para a preparaç o da combinaç o e para melhoria do início de ação terapéutica formulação farmacéutica para o suo no tratamento de distúrbios efetivos e kit
BR9902808A (pt) Compostos, composição farmacêutica, composição cosmética e uso de uma composição cosmética
BRPI9509819B8 (pt) benzamida enterocinética e composição farmacêutica compreendendo a mesma
SE8500996D0 (sv) Method of treatment
BR0207866A (pt) Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna
BR0008057A (pt) Forma cristalina de eplerenona apresentando velocidade de dissolução intensificada
US3882246A (en) Treatment of skeletal muscle disorders with cyclobenzaprine
KR890000093A (ko) 건선의 치료방법 및 치료용 조성물
BRPI9703099A (pt) derivado de carboidrato, e, composição farmacêutica
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
BR0004813A (pt) Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B25G Requested change of headquarter approved
B25A Requested transfer of rights approved

Owner name: TECHNOSTICS LIMITED (GB)

Free format text: TRANSFERIDO DE: RECKITT BENCKISER HEALTHCARE (UK) LIMITED

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 36 DA LPI .